Comparative study of clinical courses, gross lesions, acute phase response and coagulation disorders in sheep inoculated with bluetongue virus serotype 1 and 8

Veterinary Microbiology

Volumn 166, Issue 1-2, 2013, Pages 184-194

  Sanchez Cordon P J ^a   Pleguezuelos, F J ^a   Perez de Diego A C ^b   Gomez Villamandos J C ^a   Sanchez Vizcaino J M ^b   Ceron J J ^c   Tecles, F ^c   Garfia, B ^d   Pedrera, M ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c UNIVERSITY OF MURCIA   (Spain)

^d Garfia Veterinary Medicine Laboratory SL   (Spain)

Author keywords

Acute phase response; Bluetongue virus serotypes 1 and 8; Clinical signs; Coagulation disorders; Gross lesions; Sheep

Indexed keywords

ACUTE PHASE PROTEIN; ANTIBODY;

ACUTE PHASE RESPONSE; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BLOOD CLOTTING DISORDER; BLUETONGUE; BLUETONGUE ORBIVIRUS; BLUETONGUE ORBIVIRUS 1; BLUETONGUE ORBIVIRUS 8; CONTROLLED STUDY; DISEASE COURSE; NONHUMAN; PATHOGENICITY; SEROTYPE; SHEEP; THROMBOCYTOPENIA; VASCULAR LESION; VIRUS LOAD; VIRUS REPLICATION; VIRUS VIRULENCE;

ACUTE PHASE RESPONSE; BLUETONGUE VIRUS SEROTYPES 1 AND 8; CLINICAL SIGNS; COAGULATION DISORDERS; GROSS LESIONS; SHEEP;

ACUTE-PHASE PROTEINS; ACUTE-PHASE REACTION; ANIMALS; ANTIBODIES, VIRAL; BLOOD COAGULATION; BLUETONGUE; BLUETONGUE VIRUS; SHEEP; VIRULENCE;

BLUETONGUE VIRUS; OVIS ARIES;

EID: 84880511888     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2013.05.032     Document Type: Article

References (35)

1. Allepuz A., García-Bocanegra I., Napp S., Casal J., Arenas A., Saez M., González M.A. Monitoring bluetongue disease (BTV-1) epidemic in southern Spain during 2007. Prev. Vet. Med. 2010, 96:263-271.
2. Backx A., Heutink C.G., van Rooij E.M., van Rijn P.A. Clinical signs of bluetongue virus serotype 8 infection in sheep and goats. Vet. Rec. 2007, 161:591-592.
3. Bonneau K.R., Topol J.B., Gerry A.C., Mullens B.A., Velten R.K., MacLachlan N.J. Variation in the NS3/NS3A gene of bluetongue viruses contained in Culicoides sonorensis collected from a single site in southern California. Virus Res. 2002, 84:59-65.
4. Ceciliani F., Ceron J.J., Eckersall P.D., Sauerwein H. Acute phase proteins in ruminants. J. Proteomics 2012, 75:4207-4231.
5. Cerón J.J., Martínez-Subiela S. An automated spectrophotometric method for measuring canine ceruloplasmin in serum. Vet. Res. 2004, 35:671-679.
6. Darpel K.E., Batten C.A., Veronesi E., Shaw A.E., Anthony S., Bachanek-Bankowska K., Kgosana L., Bin-Tarif A., Carpenter S., Müller-Doblies U.U., Takamatsu H.H., Mellor P.S., Mertens P.P.C., Oura C.A.L. Clinical signs and pathology shown by British sheep and cattle infected with bluetongue virus serotype 8 derived from the 2006 outbreak in northern Europe. Vet. Rec. 2007, 161:253-261.
7. De Mattos C.C., de Mattos C.A., Osburn B.I., MacLachlan N.J. Evolution of the L2 gene of strains of bluetongue virus serotype 10 isolated in California. Virology 1994, 201:173-177.
8. DeMaula C.D., Leutenegger C.M., Bonneau K.R., MacLachlan N.J. The role of endothelial cell-derived inflammatory and vasoactive mediators in the pathogenesis of bluetongue. Virology 2002, 296:330-337.
9. Eckersall P.D., Bell R. Acute phase proteins: biomarkers of infection and inflammation in veterinary medicine. Vet. J. 2010, 185:23-27.
10. Elbers A.R., Backx A., Ekker H.M., van der Spek A.N., van Rijn P.A. Performance of clinical signs to detect bluetongue virus serotype 8 outbreaks in cattle and sheep during the 2006-epidemic in The Netherlands. Vet. Microbiol. 2008, 129:156-162.
11. Gómez-Villamandos J.C., Sánchez C., Carrasco L., Laviada M.M., Bautista M.J., Martínez-Torrecuadrada J., Sánchez-Vizcaíno J.M., Sierra M.A. Pathogenesis of African horse sickness: ultrastructural study of the capillaries in experimental infection. J. Comp. Pathol. 1999, 121:101-116.
12. Hamblin C., Salt J.S., Graham S.D., Hopwood K., Wade-Evans A.M. Bluetongue virus serotypes 1 and 3 infection in Poll Dorset sheep. Aust. Vet. J. 1998, 76:622-629.
13. Hamers C., Galleau S., Chery R., Blanchet M., Besancon L., Cariou C., Werle-Lapostolle B., Hudelet P., Goutebroze S. Use of inactivated bluetongue virus serotype 8 vaccine against virulent challenge in sheep and cattle. Vet. Rec. 2009, 165:369-373.
14. Hemati B., Contreras V., Urien C., Bonneau M., Takamatsu H.H., Mertens P.P., Bréard E., Sailleau C., Zientara S., Schwartz-Cornil I. Bluetongue virus targets conventional dendritic cells in skin lymph. J. Virol. 2009, 83:8789-8799.
15. Howerth E.W., Greene C.E., Prestwood A.K. Experimentally induced bluetongue virus infection in white-tailed deer: coagulation, clinical pathologic, and gross pathologic changes. Am. J. Vet. Res. 1988, 49:1906-1913.
16. Jeggo M.H., Wardley R.C., Brownlie J. A study of the role of cell-mediated immunity in bluetongue virus infection in sheep, using cellular adoptive transfer techniques. Immunology 1984, 52:403-410.
17. Maan S., Maan N.S., Nomikou K., Veronesi E., Bachanek-Bankowska K., Belaganahalli M.N., Attoui H., Mertens P.P. Complete genome characterisation of a novel 26th bluetongue virus serotype from Kuwait. PLoS ONE 2011, 6:e26147.
18. MacLachlan N.J., Crafford J.E., Vernau W., Gardner I.A., Goddard A., Guthrie A.J., Venter E.H. Experimental reproduction of severe bluetongue in sheep. Vet. Pathol. 2008, 45:310-315.
19. MacLachlan N.J., Drew C.P., Darpel K.E., Worwa G. The pathology and pathogenesis of bluetongue. J. Comp. Pathol. 2009, 141:1-16.
20. MacLachlan N.J., Guthrie A.J. Re-emergence of bluetongue, African horse sickness, and other orbivirus diseases. Vet. Res. 2010, 41:35.
21. McColl K.A., Gould A.R. Bluetongue virus infection in sheep: haematological changes and detection by polymerase chain reaction. Aust. Vet. J. 1994, 71:97-101.
22. Moulin V., Noordegraaf C.V., Makoschey B., van der Sluijs M., Veronesi E., Darpel K., Mertens P.P., de Smit H. Clinical disease in sheep caused by bluetongue virus serotype 8, and prevention by an inactivated vaccine. Vaccine 2012, 30:2228-2235.
23. Nugent D., McMillan R., Nichol J.L., Slichter S.J. Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production. Br. J. Haematol. 2009, 146:585-596.
24. Oura C.A., Wood J.L., Sanders A.J., Bin-Tarif A., Henstock M., Edwards L., Floyd T., Simmons H., Batten C.A. Seroconversion, neutralising antibodies and protection in bluetongue serotype 8 vaccinated sheep. Vaccine 2009, 27:7326-7330.
25. Perez de Diego A.C., Athmaram T.N., Stewart M., Rodriguez-Sanchez B., Sanchez-Vizcaino J.M., Noad R., Roy P. Characterization of protection afforded by a bivalent virus-like particle vaccine against bluetongue virus serotypes 1 and 4 in sheep. PLoS ONE 2011, 6:e26666.
26. Perrin A., Albina E., Bréard E., Sailleau C., Promé S., Grillet C., Kwiatek O., Russo P., Thiéry R., Zientara S., Cêtre-Sossah C. Recombinant capripoxviruses expressing proteins of bluetongue virus: evaluation of immune responses and protection in small ruminants. Vaccine 2007, 25:6774-6783.
27. Petersen H.H., Nielsen J.P., Heegaard P.M. Application of acute phase protein measurements in veterinary clinical chemistry. Vet. Res. 2004, 35:163-187.
28. Rodríguez-Sánchez B., Iglesias-Martín I., Martínez-Avilés M., Sánchez-Vizcaíno J.M. Orbiviruses in the Mediterranean basin: updated epidemiological situation of Bluetongue and new methods for the detection of BTV serotype 4. Transbound. Emerg. Dis. 2008, 55:205-214.
29. Saegerman C., Berkvens D., Mellor P.S. Bluetongue epidemiology in the European Union. Emerg. Infect. Dis. 2008, 14:539-544.
30. Sánchez-Cordón P.J., Pedrera M., Risalde M.A., Molina V., Rodríguez-Sánchez B., Núñez A., Sánchez-Vizcaíno J.M., Gómez-Villamandos J.C. Potential role of proinflammatory cytokines in the pathogenetic mechanisms of vascular lesions in goats naturally infected with bluetongue virus serotype 1. Transbound. Emerg. Dis. 2012, 10.1111/j.1865-1682.2012.01343.x.
31. Savini G., Hamers C., Conte A., Migliaccio P., Bonfini B., Teodori L., Di Ventura M., Hudelet P., Schumacher C., Caporale V. Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle. Vet. Microbiol. 2009, 133:1-8.
32. Skowronek A.J., LaFranco L., Stone-Marschat M.A., Burrage T.G., Rebar A.H., Laegreid W.W. Clinical pathology and hemostatic abnormalities in experimental African horsesickness. Vet. Pathol. 1995, 32:112-121.
33. Toussaint J.F., Sailleau C., Breard E., Zientara S., De Clercq K. Bluetongue virus detection by two real-time RT-qPCRs targeting two different genomic segments. J. Virol. Methods 2007, 140:115-123.
34. Wilson A.J., Mellor P.S. Bluetongue in Europe: past, present and future. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2009, 364:2669-2681.
35. Worwa G., Hilbe M., Chaignat V., Hofmann M.A., Griot C., Ehrensperger F., Doherr M.G., Thür B. Virological and pathological findings in bluetongue virus serotype 8 infected sheep. Vet. Microbiol. 2010, 144:264-273.